Early or Delayed AF Ablation After HF Hospitalization? Early or Delayed AF Ablation After HF Hospitalization?
Patients with AF discharged from a heart failure (HF) hospitalization showed lower all-cause and HF-related mortality if they underwent ablation within 90 days in a registry study.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - July 24, 2023 Category: Neurology Tags: Cardiology News Source Type: news
Comment on "Exploring the factors associated with decreased dynamic balance ability in older patients with heart failure" - Payal F, Bansari RB, Saveeta F.
[The publisher has not provided an abstract for this article.]
Language: en... (Source: SafetyLit)
Source: SafetyLit - July 24, 2023 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news
Roche enters partnership with Alnylam to co-develop and co-commercialise RNAi therapeutic zilebesiran to treat hypertension in patients with high cardiovascular risk
Partnership combines Roche ’s proven track record of successfully developing and launching innovative medicines worldwide withAlnylam ’s leadership in RNAi therapeuticsZilebesiran, a Phase 2 RNAi therapeutic, has best-in-disease potential for patients with hypertension at high risk of cardiovascular morbidity and mortality, by robustly and durably lowering blood pressureHypertension, the leading cause of cardiovascular disease, affects more than 1.2 billion adults worldwide. While several therapies exist, a significant unmet need, especially for high risk patients, remains.1Basel, 24 July 2023 - Roche (SIX: RO, ROG; OT...
Source: Roche Media News - July 24, 2023 Category: Pharmaceuticals Source Type: news
Roche enters partnership with Alnylam to co-develop and co-commercialise RNAi therapeutic zilebesiran to treat hypertension in patients with high cardiovascular risk
Partnership combines Roche ’s proven track record of successfully developing and launching innovative medicines worldwide withAlnylam ’s leadership in RNAi therapeuticsZilebesiran, a Phase 2 RNAi therapeutic, has best-in-disease potential for patients with hypertension at high risk of cardiovascular morbidity and mortality, by robustly and durably lowering blood pressureHypertension, the leading cause of cardiovascular disease, affects more than 1.2 billion adults worldwide. While several therapies exist, a significant unmet need, especially for high risk patients, remains.1Basel, 24 July 2023 - Roche (SIX: RO, ROG; OT...
Source: Roche Investor Update - July 24, 2023 Category: Pharmaceuticals Source Type: news
How to Manage Heart Failure With Preserved Ejection Fraction How to Manage Heart Failure With Preserved Ejection Fraction
This review provides an up-to-date framework for diagnosis and evidence-based treatment of patients with heart failure with preserved ejection fraction.JACC: Heart Failure (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 24, 2023 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
Can Patent Foramen Ovales Cause Problems?
Discussion
During fetal development, the heart primum and secundum septa grow and overlap leaving a small but important channel between the two atria. The foramen ovale is a flap valve moving blood from the right atrium into the left atrium directly and bypassing the high pressure pulmonary system. After birth and breathing air, the neonate’s lungs open up and the pulmonary vascular resistance decreases. The left atrium now has a relatively higher pressure than the right atria, and therefore pressure on the flap valve closes the foramen ovale. Usually within 6-12 months, the fusion of the primum and secundum of the f...
Source: PediatricEducation.org - July 24, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
AstraZeneca gets GCGI approval to import heart failure drug
AstraZeneca Pharma India on Monday said it has received approval from the Drugs Controller General of India to import heart failure treatment drug Dapagliflozin tablets. The company has received permission from the DCGI to import pharmaceutical formulations of a new drug for sale, the drug firm said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 24, 2023 Category: Pharmaceuticals Source Type: news
Ray Price, Indie Film Producer, Dies at 75
Ray Price, a respected producer of indie filmmaking, has died at 75 years old from heart failure after a long battle with cancer. The news was confirmed by his long-term partner Meg Madison. Price launched his film career in 1972, managing the Berkeley storefront theater the Rialto, and went on to…#rayprice #megmadison #berkeley #rialto #bayarea #renaissancetheaters #renaissance #martinscorsese #johncassavetes #ridleyscotts (Source: Reuters: Health)
Source: Reuters: Health - July 21, 2023 Category: Consumer Health News Source Type: news
Differences Identified According to Ejection Fraction in Heart Failure
THURSDAY, July 20, 2023 -- Patients with acute decompensated heart failure (ADHF) have significant differences according to left ventricular ejection fraction, according to a study recently published in BMC Cardiovascular Disorders.
Ming-Shyan Lin,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 20, 2023 Category: Pharmaceuticals Source Type: news
Historical Redlining Linked to Risk for Heart Failure in Black Adults
WEDNESDAY, July 19, 2023 -- Among Black Medicare beneficiaries, historical redlining, a marker of structural racism, is associated with heart failure risk, according to a study published online July 17 in Circulation.
Amgad Mentias, M.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 19, 2023 Category: Pharmaceuticals Source Type: news
Redlining May Raise Heart Failure Risk Among Black Americans
TUESDAY, July 18, 2023 -- In areas where Black Americans have been historically affected by discriminatory housing practices, there is higher heart failure risk, according to new research.
Researchers studying more than 2.3 million U.S. adults... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 18, 2023 Category: General Medicine Source Type: news
Black people in redlined neighborhoods face higher risks for heart failure
Black adults living in zip codes historically impacted by redlining have an 8% higher risk of developing heart failure than Black adults in non-redlined areas, a study published Monday in the American Heart Association's scientific journal Circulation says. (Source: CNN.com - Health)
Source: CNN.com - Health - July 18, 2023 Category: Consumer Health News Source Type: news
Best Practices for SGLT2 Inhibitors in HFpEF Treatment Best Practices for SGLT2 Inhibitors in HFpEF Treatment
Drs Matthew Konerman and Sarah Adie share expert insights on SGLT2 inhibitor use in managing heart failure with preserved ejection fraction.American College of Cardiology & Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 17, 2023 Category: Cardiology Tags: Cardiology Commentary Source Type: news
Historic redlining linked to worse cardiovascular health for veterans
Patients living in formerly redlined neighborhoods were likelier to be diagnosed with chronic kidney disease, heart failure, diabetes and COPD. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - July 16, 2023 Category: Consumer Health News Authors: Erin Blakemore Source Type: news
Carpal Tunnel Syndrome Tied to Increased Incidence of Heart Failure
FRIDAY, July 14, 2023 -- Carpal tunnel syndrome (CTS) is associated with an increased incidence of new-onset heart failure, according to a research letter published online July 12 in JAMA Network Open.
Mark Luedde, M.D., from the University of Kiel... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 14, 2023 Category: Pharmaceuticals Source Type: news
